As of July 22, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as ...

AI models weren't that good at coding. Then, in the summer of 2024, Anthropic released a new model that blew everyone away.

What makes the human brain distinctive? A new study published July 21 in Cell identifies two genes linked to human brain ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) saw its stock surge 19% Monday morning following the announcement of its ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best small cap AI stocks to buy according to analysts. On July 8, ...

RXRX gains 5.5% in a month on positive pipeline update; long-term hold advised given strong potential of its AI-driven drug discovery platform.

One computer scientist’s “stunning” proof is the first progress in 50 years on one of the most famous questions in computer ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Shares of Recursion Pharmaceuticals climbed after the company said it has agreed to purchase Rallybio's interest in a drug-development plan that aims to treat a rare genetic bone disease. The stock ...

Rallybio Corp., a New Haven-based biotechnology company developing therapies for rare diseases, said Tuesday it has agreed to ...